106 related articles for article (PubMed ID: 23221432)
1. Increased Nanog expression promotes tumor development and Cisplatin resistance in human esophageal cancer cells.
Yang L; Zhang X; Zhang M; Zhang J; Sheng Y; Sun X; Chen Q; Wang LX
Cell Physiol Biochem; 2012; 30(4):943-52. PubMed ID: 23221432
[TBL] [Abstract][Full Text] [Related]
2. Nanog siRNA plus Cisplatin may enhance the sensitivity of chemotherapy in esophageal cancer.
Du Y; Shi L; Wang T; Liu Z; Wang Z
J Cancer Res Clin Oncol; 2012 Oct; 138(10):1759-67. PubMed ID: 22714588
[TBL] [Abstract][Full Text] [Related]
3. Hyaluronan-CD44 interaction with protein kinase C(epsilon) promotes oncogenic signaling by the stem cell marker Nanog and the Production of microRNA-21, leading to down-regulation of the tumor suppressor protein PDCD4, anti-apoptosis, and chemotherapy resistance in breast tumor cells.
Bourguignon LY; Spevak CC; Wong G; Xia W; Gilad E
J Biol Chem; 2009 Sep; 284(39):26533-46. PubMed ID: 19633292
[TBL] [Abstract][Full Text] [Related]
4. The usefulness of three-dimensional cell culture in induction of cancer stem cells from esophageal squamous cell carcinoma cell lines.
Fujiwara D; Kato K; Nohara S; Iwanuma Y; Kajiyama Y
Biochem Biophys Res Commun; 2013 May; 434(4):773-8. PubMed ID: 23602898
[TBL] [Abstract][Full Text] [Related]
5. [Effects of NANOG gene down-regulation on the apoptosis of T-cell acute lymphoblastic leukemia cells].
Cao J; Li L; Lyu C; Meng FJ; Zhou J; Chen C; Zeng LY; Li ZY; Xu KL
Zhonghua Xue Ye Xue Za Zhi; 2013 Dec; 34(12):1001-5. PubMed ID: 24369153
[TBL] [Abstract][Full Text] [Related]
6. Stem cell-like side populations in esophageal cancer: a source of chemotherapy resistance and metastases.
Zhao Y; Bao Q; Schwarz B; Zhao L; Mysliwietz J; Ellwart J; Renner A; Hirner H; Niess H; Camaj P; Angele M; Gros S; Izbicki J; Jauch KW; Nelson PJ; Bruns CJ
Stem Cells Dev; 2014 Jan; 23(2):180-92. PubMed ID: 24021093
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of NANOG enhances chemosensitivity of liver cancer cells to doxorubicin by reducing MDR1 expression.
Zhou JJ; Deng XG; He XY; Zhou Y; Yu M; Gao WC; Zeng B; Zhou QB; Li ZH; Chen RF
Int J Oncol; 2014 Jun; 44(6):2034-40. PubMed ID: 24647772
[TBL] [Abstract][Full Text] [Related]
8. Research of the mechanism on miRNA193 in exosomes promotes cisplatin resistance in esophageal cancer cells.
Shi S; Huang X; Ma X; Zhu X; Zhang Q
PLoS One; 2020; 15(5):e0225290. PubMed ID: 32369495
[TBL] [Abstract][Full Text] [Related]
9. MiR-499 Enhances the Cisplatin Sensitivity of Esophageal Carcinoma Cell Lines by Targeting DNA Polymerase β.
Wang Y; Feng J; Zang W; Du Y; Chen X; Sun Q; Dong Z; Zhao G
Cell Physiol Biochem; 2015; 36(4):1587-96. PubMed ID: 26159783
[TBL] [Abstract][Full Text] [Related]
10. Nanog is a promising chemoresistant stemness marker and therapeutic target by iron chelators for esophageal cancer.
Narusaka T; Ohara T; Noma K; Nishiwaki N; Katsura Y; Kato T; Sato H; Tomono Y; Kikuchi S; Tazawa H; Shirakawa Y; Matsukawa A; Fujiwara T
Int J Cancer; 2021 Jul; 149(2):347-357. PubMed ID: 33662150
[TBL] [Abstract][Full Text] [Related]
11. Markedly increased Oct4 and Nanog expression correlates with cisplatin resistance in oral squamous cell carcinoma.
Tsai LL; Yu CC; Chang YC; Yu CH; Chou MY
J Oral Pathol Med; 2011 Sep; 40(8):621-8. PubMed ID: 21342274
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling of the response of esophageal carcinoma cells to cisplatin.
Takashima N; Ishiguro H; Kuwabara Y; Kimura M; Mitui A; Mori Y; Mori R; Tomoda K; Hamaguchi M; Ogawa R; Katada T; Harada K; Fujii Y
Dis Esophagus; 2008; 21(3):230-5. PubMed ID: 18430104
[TBL] [Abstract][Full Text] [Related]
13. Endoplasmic reticulum stress could induce autophagy and apoptosis and enhance chemotherapy sensitivity in human esophageal cancer EC9706 cells by mediating PI3K/Akt/mTOR signaling pathway.
Zhou F; Li YH; Wang JJ; Pan J; Lu H
Tumour Biol; 2017 Jun; 39(6):1010428317705748. PubMed ID: 28631572
[TBL] [Abstract][Full Text] [Related]
14. Stem cell transcription factor NANOG in cancers--is eternal youth a curse?
Wong OG; Cheung AN
Expert Opin Ther Targets; 2016; 20(4):407-17. PubMed ID: 26634876
[TBL] [Abstract][Full Text] [Related]
15. Expression analysis of iPS cell - inductive genes in esophageal squamous cell carcinoma by tissue microarray.
Shimada Y; Okumura T; Sekine S; Moriyama M; Sawada S; Matsui K; Yoshioka I; Hojo S; Yoshida T; Nagata T; Fukuoka J; Tsukada K
Anticancer Res; 2012 Dec; 32(12):5507-14. PubMed ID: 23225459
[TBL] [Abstract][Full Text] [Related]
16.
Hou XF; Xu LP; Song HY; Li S; Wu C; Wang JF
World J Gastroenterol; 2017 Mar; 23(10):1796-1803. PubMed ID: 28348485
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of ZFX confers self-renewal and chemoresistance properties in hepatocellular carcinoma.
Lai KP; Chen J; He M; Ching AK; Lau C; Lai PB; To KF; Wong N
Int J Cancer; 2014 Oct; 135(8):1790-9. PubMed ID: 24585547
[TBL] [Abstract][Full Text] [Related]
18. PITX2: a promising predictive biomarker of patients' prognosis and chemoradioresistance in esophageal squamous cell carcinoma.
Zhang JX; Tong ZT; Yang L; Wang F; Chai HP; Zhang F; Xie MR; Zhang AL; Wu LM; Hong H; Yin L; Wang H; Wang HY; Zhao Y
Int J Cancer; 2013 Jun; 132(11):2567-77. PubMed ID: 23132660
[TBL] [Abstract][Full Text] [Related]
19. Reduced tumorigenicity and drug resistance through the downregulation of octamer-binding protein 4 and Nanog transcriptional factor expression in human breast stem cells.
Huang ZJ; You J; Luo WY; Chen BS; Feng QZ; Wu BL; Jiang L; Luo Q
Mol Med Rep; 2015 Mar; 11(3):1647-54. PubMed ID: 25405855
[TBL] [Abstract][Full Text] [Related]
20. Tetrandrine enhances cytotoxicity of cisplatin in human drug-resistant esophageal squamous carcinoma cells by inhibition of multidrug resistance-associated protein 1.
Wang TH; Wan JY; Gong X; Li HZ; Cheng Y
Oncol Rep; 2012 Nov; 28(5):1681-6. PubMed ID: 22941407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
